The SynGAP Research Fund (SRF) dba Cure SYNGAP1, a 501(c)(3) nonprofit organization, has awarded a $65,000 grant to Dr. Julia ...
Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...
The development could pave the way for therapies for rare disorders including some forms of cancer. It also holds potential for therapies to treat immune system and neurodegenerative disorders, ...
Dr. Julia Dallman, Associate Professor of Biology at the University of Miami, alongside her research team, received a $65,000 grant from the SynGAP Research Fund (SRF). This funding supports their ...
As the SynGAP protein supports the development and strengthening of synapses, enabling healthy communication between neurons, the lower production of this protein can adversely impact brain function.